JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109493

Anti-IgG4 antibody [EP4420]

Be the first to review this product! Submit a review

|

(30 Publications)

Anti-IgG4 antibody [EP4420] (ab109493) is a rabbit monoclonal antibody detecting IgG4 in Western Blot, IHC-P. Suitable for Human,.

- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications

View Alternative Names

Immunoglobulin heavy constant gamma 4, Ig gamma-4 chain C region, IGHG4

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IgG4 antibody [EP4420] (AB109493)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IgG4 antibody [EP4420] (AB109493)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human tonsil tissue sections labeling IgG4 with Purified ab109493 at 1 : 4000 dilution (0.023 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ImmunoHistoProbe one step HRP Polymer (ready to use) secondary antibody was used. PBS instead of the primary antibody was used as the negative control.

Western blot - Anti-IgG4 antibody [EP4420] (AB109493)
  • WB

Unknown

Western blot - Anti-IgG4 antibody [EP4420] (AB109493)

All lanes:

Western blot - Anti-IgG4 antibody [EP4420] (ab109493) at 1/1000 dilution

Lane 1:

Human spleen lysate at 15 µg

Lane 2:

Human plasma lysate at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Predicted band size: 36 kDa

Observed band size: 52 kDa

false

Western blot - Anti-IgG4 antibody [EP4420] (AB109493)
  • WB

Lab

Western blot - Anti-IgG4 antibody [EP4420] (AB109493)

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 180 seconds.

All lanes:

Western blot - Anti-IgG4 antibody [EP4420] (ab109493) at 1/1000 dilution

Lane 1:

IgG4 Recombinant protein at 0.005 µg

Lane 2:

IgG1 Recombinant protein at 0.01 µg

Lane 3:

IgG2 Recombinant protein at 0.01 µg

Lane 4:

IgG3 Recombinant protein at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 36 kDa

Observed band size: 52 kDa

false

  • Carrier free

    Anti-IgG4 antibody [EP4420] - BSA and Azide free

  • HRP

    HRP Anti-IgG4 antibody [EP4420]

  • Carrier free

    Anti-IgG4 antibody [EP4420] - Low endotoxin, Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP4420

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Does not cross-react with IgG1, IgG2, or IgG3.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000 - 1/5000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Recombinant fragment - Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p><strong>For unpurified, use at 1/1000 - 1/10000.</strong></p>" } } }

Product details

What is this antibody validated in?
Anti-IgG4 antibody [EP4420] (ab109493) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human, samples.

What is the molecular weight of IgG4?
Anti-IgG4 [EP4420] (ab109493) specifically detects a band for IgG4 (UniProt: P01861) at a molecular weight of 36kDa.

Trusted by the scientific community
Anti-IgG4 [EP4420] (ab109493) was first used in a scientific publication in 2011 and has been cited over 20 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EP4420] also available for your convenience: ab109493, Carrier free - ab186921, Carrier free - ab271883, HRP - ab323344

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region interacts (via the fragment crystallizable, Fc) with the Fc receptors on innate immune cells to mediate humoral effector functions. Ig gamma-4 (IgG4) isotype does not elicit antibody-dependent cellular cytotoxicity (ADDC) or complement-dependent cytotoxicity (CDC). Instead it is likely involved in immune tolerance mechanisms to allergens and parasites either by blocking IgE-antigen complex formation or by directly inhibiting mast cell degranulation through Fc receptor signaling. In the context of tumorigenesis, it may participate in immunosuppressive mechanisms.
See full target information IGHG4

Publications (30)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1654655 PubMed41050654

2025

Increased IgG4 expression within tertiary lymphoid structures of esophageal cancer and implications for prognosis.

Applications

Unspecified application

Species

Unspecified reactive species

Chanjuan Su,Shuqi Chen,Xuqing He,Changchun Ma,Wei Huang,Chunyan Zhu,Hui Wang,Jiang Gu

The American Journal of dermatopathology 47:110-113 PubMed39851904

2025

Immunohistochemistry for Immunoglobulin G4 on Paraffin Sections as a Diagnostic Test for Pemphigus.

Applications

Unspecified application

Species

Unspecified reactive species

Tsvetana I Abadjieva,Sylvia N Genova,Mina M Pencheva,Zhaneta H Zhelyazkova

Alzheimer's & dementia : the journal of the Alzheimer's Association 21:e14401 PubMed39698934

2024

Alzheimer's disease-associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brain.

Applications

Unspecified application

Species

Unspecified reactive species

Benjamin P Readhead,Diego F Mastroeni,Qi Wang,Maria A Sierra,Camila de Ávila,Tajudeen O Jimoh,Jean-Vianney Haure-Mirande,Kristina E Atanasoff,Jennifer Nolz,Crystal Suazo,Nathaniel J Barton,Adrian R Orszulak,Samantha M Chigas,Khanh Tran,Anne Mirza,Krista Ryon,Jacqueline Proszynski,Deena Najjar,Joel T Dudley,Sean T H Liu,Sam Gandy,Michelle E Ehrlich,Eric Alsop,Jerry Antone,Rebecca Reiman,Cory Funk,Rebecca L Best,Michael Jhatro,Kathy Kamath,John Shon,Timothy F Kowalik,David A Bennett,Winnie S Liang,Geidy E Serrano,Thomas G Beach,Kendall Van Keuren-Jensen,Christopher E Mason,Yingleong Chan,Elaine T Lim,Domenico Tortorella,Eric M Reiman

European thyroid journal 13: PubMed39316722

2024

IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chenxu Zhao,Zhiming Sun,Shuaihang Wang,Jixin Zhang,Jumei Liu,Lei Chen,Guizhi Lu,Yang Yu,Ying Gao

ImmunoHorizons 7:366-379 PubMed37219538

2023

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

Applications

Unspecified application

Species

Unspecified reactive species

Michael C Warren,Stephan Matissek,Matthew Rausch,Marisella Panduro,R J Hall,Austin Dulak,David Brennan,Sonia Das Yekkirala,Secil Koseoglu,Ricard Masia,Yu Yang,Navamallika Reddy,Robert Prenovitz,Jamie Strand,Tauqueer Zaidi,Erik Devereaux,Célia Jacoberger Foissac,John Stagg,Benjamin H Lee,Pamela Holland,Vito J Palombella,Andrew C Lake

Neuropathology : official journal of the Japanese Society of Neuropathology 43:176-180 PubMed36226609

2022

A unique case of isolated thoracic spinal Rosai-Dorfman disease related to IgG4.

Applications

Unspecified application

Species

Unspecified reactive species

Ayşen Terzi,Çiğdem Sercan,Fikret Şahintürk

Journal of clinical medicine 11: PubMed35888006

2022

Esophageal Mucosal Permeability as a Surrogate Measure of Cure in Eosinophilic Esophagitis.

Applications

Unspecified application

Species

Unspecified reactive species

Junji Chen,Tadayuki Oshima,Xinyi Huang,Toshihiko Tomita,Hirokazu Fukui,Hiroto Miwa

Journal of translational medicine 20:112 PubMed35255925

2022

Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Nicole J Toney,Lynn M Opdenaker,Kader Cicek,Lisa Frerichs,Christopher Ryan Kennington,Samuel Oberly,Holly Archinal,Rajasekharan Somasundaram,Jennifer Sims-Mourtada

Journal of proteome research 21:274-288 PubMed34878788

2021

Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.

Applications

Unspecified application

Species

Unspecified reactive species

Rafael D Melani,Benjamin J Des Soye,Jared O Kafader,Eleonora Forte,Michael Hollas,Voislav Blagojevic,Fernanda Negrão,John P McGee,Bryon Drown,Cameron Lloyd-Jones,Henrique S Seckler,Jeannie M Camarillo,Philip D Compton,Richard D LeDuc,Bryan Early,Ryan T Fellers,Byoung-Kyu Cho,Basil Baby Mattamana,Young Ah Goo,Paul M Thomas,Michelle K Ash,Pavan P Bhimalli,Lena Al-Harthi,Beverly E Sha,Jeffrey R Schneider,Neil L Kelleher

Digestive diseases and sciences 67:3639-3648 PubMed34499268

2021

Gastrointestinal IgG4 Deposition Is a New Histopathological Feature of Eosinophilic Gastroenteritis.

Applications

Unspecified application

Species

Unspecified reactive species

Satoshi Kosaka,Fumio Tanaka,Akinobu Nakata,Yuji Nadatani,Shusei Fukunaga,Koji Otani,Shuhei Hosomi,Noriko Kamata,Yasuaki Nagami,Koichi Taira,Toshio Watanabe,Yasuhiro Fujiwara
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com